Free Trial

MaxCyte (MXCT) Competitors

MaxCyte logo
GBX 162.23 -6.27 (-3.72%)
As of 06/13/2025 11:04 AM Eastern

MXCT vs. RSG, OCN, PAY, LOOK, CSN, TRMR, HUR, ACRL, TRU, and TUNG

Should you be buying MaxCyte stock or one of its competitors? The main competitors of MaxCyte include Resolute Mining (RSG), Ocean Wilsons (OCN), PayPoint (PAY), Lookers (LOOK), Chesnara (CSN), Tremor International (TRMR), Hurricane Energy (HUR), Accrol Group (ACRL), TruFin (TRU), and Tungsten (TUNG). These companies are all part of the "business services" industry.

MaxCyte vs. Its Competitors

Resolute Mining (LON:RSG) and MaxCyte (LON:MXCT) are both small-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, dividends and risk.

Resolute Mining has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Resolute Mining, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Resolute Mining£817.76M0.88£15.35M£0.4658.43
MaxCyte£57.52M3.72-£45.08M-£27.29-5.94

In the previous week, MaxCyte had 2 more articles in the media than Resolute Mining. MarketBeat recorded 2 mentions for MaxCyte and 0 mentions for Resolute Mining. MaxCyte's average media sentiment score of 0.38 beat Resolute Mining's score of 0.00 indicating that MaxCyte is being referred to more favorably in the news media.

Company Overall Sentiment
Resolute Mining Neutral
MaxCyte Neutral

Resolute Mining has a net margin of 1.88% compared to MaxCyte's net margin of -78.37%. Resolute Mining's return on equity of 1.90% beat MaxCyte's return on equity.

Company Net Margins Return on Equity Return on Assets
Resolute Mining1.88% 1.90% 6.41%
MaxCyte -78.37%-16.01%-11.07%

Resolute Mining presently has a consensus price target of GBX 38, suggesting a potential upside of 41.26%. Given Resolute Mining's stronger consensus rating and higher probable upside, equities research analysts plainly believe Resolute Mining is more favorable than MaxCyte.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Resolute Mining
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
MaxCyte
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

MaxCyte received 101 more outperform votes than Resolute Mining when rated by MarketBeat users. However, 89.66% of users gave Resolute Mining an outperform vote while only 68.92% of users gave MaxCyte an outperform vote.

CompanyUnderperformOutperform
Resolute MiningOutperform Votes
52
89.66%
Underperform Votes
6
10.34%
MaxCyteOutperform Votes
153
68.92%
Underperform Votes
69
31.08%

69.0% of Resolute Mining shares are held by institutional investors. Comparatively, 70.5% of MaxCyte shares are held by institutional investors. 4.3% of Resolute Mining shares are held by insiders. Comparatively, 1.5% of MaxCyte shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Resolute Mining has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, MaxCyte has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500.

Summary

Resolute Mining beats MaxCyte on 13 of the 18 factors compared between the two stocks.

Get MaxCyte News Delivered to You Automatically

Sign up to receive the latest news and ratings for MXCT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MXCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MXCT vs. The Competition

MetricMaxCyteMedical Devices IndustryMedical SectorLON Exchange
Market Cap£214.15M£3.26B£5.57B£2.91B
Dividend YieldN/A2.44%5.27%4.90%
P/E Ratio-5.9473.7126.75124.60
Price / Sales3.72113.49403.98248,064.88
Price / Cash1.9715.9938.2528.07
Price / Book0.803.876.964.64
Net Income-£45.08M£126.02M£3.23B£5.91B
7 Day Performance-2.57%-0.81%-1.22%6.61%
1 Month Performance0.45%5.71%6.34%13.53%
1 Year Performance-57.31%-5.14%33.05%78.98%

MaxCyte Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MXCT
MaxCyte
N/AGBX 162.23
-3.7%
N/A-57.3%£214.15M£57.52M-5.9480News Coverage
Negative News
Gap Down
RSG
Resolute Mining
1.8867 of 5 stars
GBX 27.70
+0.2%
GBX 38
+37.2%
-0.7%£738.02M£817.76M60.1740,000
OCN
Ocean Wilsons
N/AGBX 1,505
flat
N/A+14.2%£663.56M£647.52M10.7574,200News Coverage
PAY
PayPoint
N/AGBX 759
-1.3%
N/A+29.0%£543.52M£301.14M15.591,260News Coverage
Earnings Report
Dividend Increase
LOOK
Lookers
N/AN/AN/AN/A£503.22M£4.48B811.2538
CSN
Chesnara
N/AGBX 294.73
+0.1%
N/A+17.0%£448.46M£412.72M107.505,700
TRMR
Tremor International
N/AN/AN/AN/A£293.13M£343.77M-1,829.09167
HUR
Hurricane Energy
N/AN/AN/AN/A£155.02M£275.50M194.755,660High Trading Volume
ACRL
Accrol Group
N/AN/AN/AN/A£124.36M£221.16M-3,900.00456
TRU
TruFin
N/AGBX 88
-1.1%
N/A+8.9%£93.25M£34.97M36.5812,200
TUNG
Tungsten
N/AN/AN/AN/A£69.09M£36.39M-19.50200

Related Companies and Tools


This page (LON:MXCT) was last updated on 6/15/2025 by MarketBeat.com Staff
From Our Partners